Stay updated on Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    An NIH announcement about the transition from “Artificial Intelligence” to “Super Intelligence” appears above the 403 error page. The site revision changes from v3.7.1 to v3.7.2.
    Difference
    1%
    Check dated 2026-10-20T20:36:07.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision identifier changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-06T20:10:24.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The study record page now displays a 403 error, replacing the full trial details with an access-restricted page. This change prevents users from viewing core information about the trial, including its design, eligibility criteria, locations, and related documents.
    Difference
    19%
    Check dated 2026-09-22T22:23:34.000Z thumbnail image
  6. Check
    47 days ago
    Change Detected
    Summary
    The page now shows revision: v3.7.0, replacing the previous revision: v3.6.6. This indicates a new version of the page content without changing the study details.
    Difference
    0.0%
    Check dated 2026-09-15T21:44:41.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    A new page revision tag v3.6.6 was added to the page metadata. The previous revision tag v3.6.5 was removed.
    Difference
    0.0%
    Check dated 2026-09-01T18:36:45.000Z thumbnail image
  8. Check
    68 days ago
    Change Detected
    Summary
    A new NIH grant/contract identifier (2018) was added to the study's identifiers, representing funding information for the trial.
    Difference
    0.0%
    Check dated 2026-08-25T19:53:17.000Z thumbnail image

Stay in the know with updates to Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Placebo in Locally Advanced Cutaneous SCC Clinical Trial page.